Related Experiment Video
Updated: Dec 3, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long noncoding RNA LINC00657 inhibits cervical cancer development by sponging miR-20a-5p and targeting RUNX3
Xiaomin Qin1, Min Zhou1, Huabing Lv1
1Department of Obstetrics and Gynecology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China.
Abstract:
Long noncoding RNAs act essential regulators in cervical cancer progression. Our study aimed to investigate the underlying function and molecular mechanisms of LINC00657 in cervical cancer. QRT-PCR results indicated that LINC00657 was significantly decreased in cervical cancer. Gain-and loss-of-function experiments were performed in SiHa and HeLa. Functional assays demonstrated that LINC00657 inhibited cervical cancer cell growth, migration and invasion. Moreover, miR-20a-5p was confirmed as a target of LINC00657. Furthermore, miR-20a-5p promoted the development of cervical cancer via targeting RUNX3. DR5 acts as a vital promoter in activating NK cells and is a downstream target of RUNX3. We found that LINC00657 overexpression promoted the cytotoxic activity of NK cells via regulating RUNX3/DR5 axis. Therefore, LINC00657 suppressed cervical cancer progression via inducing miR-20a-5p/RUNX3/DR5 mediated NK cell tolerance. In conclusion, LINC00657 was identified as a novel tumor-suppressor in cervical cancer and could function as a potential therapeutic target for clinical treatment.
Insights
Long noncoding RNA LINC00657 suppresses cervical cancer progression by inhibiting cell growth and invasion. It enhances natural killer cell activity through the miR-20a-5p/RUNX3/DR5 pathway, offering a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Immunology
Background:
- Long noncoding RNAs (lncRNAs) are crucial in cancer development.
- The role of LINC00657 in cervical cancer remains largely unexplored.
Purpose of the Study:
- To elucidate the function and molecular mechanisms of LINC00657 in cervical cancer.
- To investigate LINC00657's potential as a therapeutic target.
Main Methods:
- Quantitative Reverse Transcription Polymerase Chain Reaction (QRT-PCR) for expression analysis.
- Gain-and loss-of-function experiments in cervical cancer cell lines (SiHa, HeLa).
- Functional assays to assess cell growth, migration, and invasion; miRNA target validation; Western blotting and NK cell activity assays.
Main Results:
- LINC00657 expression was significantly downregulated in cervical cancer tissues.
- Overexpression of LINC00657 inhibited cervical cancer cell proliferation, migration, and invasion.
- LINC00657 negatively regulated miR-20a-5p, which targets RUNX3.
- LINC00657 promoted NK cell cytotoxic activity via the RUNX3/DR5 axis, reducing tumor immune evasion.
Conclusions:
- LINC00657 acts as a tumor suppressor in cervical cancer.
- The LINC00657/miR-20a-5p/RUNX3/DR5 pathway modulates NK cell activity and cervical cancer progression.
- LINC00657 represents a promising therapeutic target for cervical cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Inheritance of Chromatin Structures
Experimental RNAi
